Until now all a veterinarian could do to treat a cat with the most common form of heart disease was try to make the animal more comfortable and ameliorate the ravages of the illness by treating symptoms. But a new drug appears to be able to literally reverse the disease, which affects an estimated 15 percent of cats. The Food and Drug Administration is encouraged enough by the results of initial studies that it has granted the drug “expanded conditional approval,” meaning veterinarians can prescribe it while a major clinical trial is underway.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Tufts Catnip
Get the next year of TUFTS CATNIP for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 44%. It's like getting 5 months FREE!
